4//SEC Filing
Hindman Andrew A. 4
Accession 0001415889-22-005631
CIK 0001583107other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:17 PM ET
Size
5.1 KB
Accession
0001415889-22-005631
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2022-05-20$8.74/sh−3,365$29,410→ 479,183 total
Footnotes (2)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
- [F2]Includes 1,263 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2022.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 7:17 PM ET
- Size
- 5.1 KB